2022
Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction
Nam D, Chapiro J, Paradis V, Seraphin TP, Kather JN. Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction. JHEP Reports 2022, 4: 100443. PMID: 35243281, PMCID: PMC8867112, DOI: 10.1016/j.jhepr.2022.100443.Peer-Reviewed Original ResearchArtificial intelligenceSuch AI systemsDiverse clinical datasetsDeep learningAI systemsMultiple data sourcesDecision support toolImage dataLarge-scale clinical validationSupport toolRadiology dataClinical datasetsData sourcesRelevant informationIntelligenceClinical routineDisease courseLiver diseaseInformationNovel biomarkersNeoplastic diseaseHepatologyClinical validationCritical obstacleDataset
2020
Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer
Miszczuk MA, Chapiro J, Geschwind JH, Thakur V, Nezami N, Laage-Gaupp F, Kulon M, van Breugel JMM, Fereydooni A, Lin M, Savic LJ, Tegel B, Wahlin T, Funai E, Schlachter T. Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer. Translational Oncology 2020, 13: 100742. PMID: 32092672, PMCID: PMC7036424, DOI: 10.1016/j.tranon.2020.01.003.Peer-Reviewed Original Research